Five Prime Therapeutics, Inc. Pre-Tax Profit Margin 2013-2020 | FPRX
Five Prime Therapeutics, Inc. pre-tax profit margin from 2013 to 2020. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2020-12-31 | $0.01B | $-0.09B | -758.33% |
| 2020-09-30 | $0.02B | $-0.10B | -631.25% |
| 2020-06-30 | $0.02B | $-0.10B | -611.76% |
| 2020-03-31 | $0.02B | $-0.12B | -711.76% |
| 2019-12-31 | $0.01B | $-0.14B | -971.43% |
| 2019-09-30 | $0.02B | $-0.14B | -960.00% |
| 2019-06-30 | $0.02B | $-0.16B | -861.11% |
| 2019-03-31 | $0.02B | $-0.16B | -673.91% |
| 2018-12-31 | $0.05B | $-0.14B | -280.00% |
| 2018-09-30 | $0.06B | $-0.13B | -220.34% |
| 2018-06-30 | $0.06B | $-0.13B | -206.56% |
| 2018-03-31 | $0.06B | $-0.14B | -221.31% |
| 2017-12-31 | $0.04B | $-0.15B | -379.49% |
| 2017-09-30 | $0.03B | $-0.15B | -441.18% |
| 2017-06-30 | $0.03B | $-0.13B | -403.03% |
| 2017-03-31 | $0.03B | $-0.11B | -323.53% |
| 2016-12-31 | $0.03B | $-0.10B | -312.90% |
| 2016-09-30 | $0.39B | $0.27B | 69.43% |
| 2016-06-30 | $0.39B | $0.27B | 70.13% |
| 2016-03-31 | $0.38B | $0.28B | 73.04% |
| 2015-12-31 | $0.38B | $0.29B | 75.99% |
| 2015-09-30 | $0.02B | $-0.06B | -276.19% |
| 2015-06-30 | $0.02B | $-0.04B | -195.24% |
| 2015-03-31 | $0.02B | $-0.04B | -200.00% |
| 2014-12-31 | $0.02B | $-0.04B | -190.00% |
| 2014-09-30 | $0.02B | $-0.03B | -173.68% |
| 2014-06-30 | $0.02B | $-0.03B | -206.25% |
| 2014-03-31 | $0.02B | $-0.03B | -200.00% |
| 2013-12-31 | $0.01B | $-0.03B | -200.00% |
| 2013-09-30 | $0.01B | $-0.03B | -207.69% |
